









Markets
/
Stocks
/
nasdaq-sint
/

SINTX Technologies Inc

SINT

2.940USD

+0.040+1.38%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

10.63MMarket Cap

LossP/E TTM



SINTX Technologies Inc

2.940

+0.040+1.38%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of SINTX Technologies Inc

Currency: USD Updated: 2026-02-06

Key Insights

SINTX Technologies Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is good.Its valuation is considered fairly valued, ranking 130 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 16.00.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

SINTX Technologies Inc's Score

Industry at a Glance

Industry Ranking

130 / 205

Overall Ranking

377 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

SINTX Technologies Inc Highlights

StrengthsRisks

SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 84.95% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 2.89M.

Undervalued

The company’s latest PE is -0.79, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 459.74K shares, increasing 14.17% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 44.44K shares of this stock.

Analyst Rating

Based on 1 analysts

Buy

Current Rating

16.000

Target Price

+451.72%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of SINTX Technologies Inc is 5.54, ranking 196 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 208.00K, representing a year-over-year decrease of 73.97%, while its net profit experienced a year-over-year decrease of 64.42%.

Score

Industry at a Glance

Previous score

5.54

Change



Financials

7.28

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.17

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.83

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

3.32

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.07

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

SINTX Technologies Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of SINTX Technologies Inc is 8.79, ranking 7 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.79, which is -98.70% below the recent high of -0.01 and -44.89% above the recent low of -1.14.

Score

Industry at a Glance

Previous score

8.79

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 130/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of SINTX Technologies Inc is 8.00, ranking 60 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 16.00, with a high of 16.00 and a low of 16.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 1 analysts

Buy

Current Rating

16.000

Target Price

+451.72%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

114

Total

Median

Average

Company name

Ratings

Analysts

SINTX Technologies Inc

SINT

Stryker Corp

SYK

Medtronic PLC

MDT

Dexcom Inc

DXCM

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of SINTX Technologies Inc is 1.75, ranking 202 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 3.64 and the support level at 2.53, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

1.86

Change

-0.11

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.119

Sell

RSI(14)

27.654

Sell

STOCH(KDJ)(9,3,3)

15.554

Oversold

ATR(14)

0.151

Low Volatility

CCI(14)

-105.489

Sell

Williams %R

87.368

Oversold

TRIX(12,20)

-0.720

Sell

StochRSI(14)

38.072

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

3.045

Sell

MA10

3.188

Sell

MA20

3.430

Sell

MA50

3.621

Sell

MA100

3.721

Sell

MA200

3.432

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of SINTX Technologies Inc is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 12.15%, representing a quarter-over-quarter increase of 53.74%. The largest institutional shareholder is The Vanguard, holding a total of 44.44K shares, representing 1.15% of shares outstanding, with 4.65% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Medtech Ceramics LP

250.08K

Honigblum (Gregg R.)

201.07K

+130.43%

Murphy (Kevin Patrick)

138.96K

DRW Securities, LLC

110.35K

Commonwealth Financial Network

94.93K

Veracity Capital LLC

79.93K

+10.30%

Olson Eric K

44.82K

+14.86%

The Vanguard Group, Inc.

Star Investors

30.43K

Renaissance Technologies LLC

Star Investors

27.55K

Geode Capital Management, L.L.C.

17.36K

+13.17%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of SINTX Technologies Inc is 1.90, ranking 171 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.67. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.